Point Of Care Diagnostics Market Size, Share, Growth Analysis, By Sample(Blood Samples, Urine Samples, Nasal & Oropharyngeal Swabs, and Other Samples), By Product Type(Glucose Monitoring Products (Strips, Meters, Lancets & Lancing Devices), Covid-19 Testing Products), By End-Users(Clinical Laboratories, Ambulatory Care Facilities and Physicians Offices, Pharmacies, Retail Clinics), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2098 | Region: Global | Published Date: June, 2024
Pages: 157 |Tables: 121 |Figures: 77

Point Of Care Diagnostics Market Insights

Global Point of Care Diagnostics Market size was valued at USD 47.64 Billion in 2022 and is poised to grow from USD 50.54 Billion in 2023 to USD 81.17 Billion by 2031, at a CAGR of 6.1% during the forecast period (2024-2031).

The Point of Care Diagnostics (POCD) market denotes a medical testing done nearby or even at the site of patient care falling under the umbrella of rapid diagnosis which is usually within few minutes to support in clinical decision-making. This market is also behind the design and manufacturing of diverse diagnostic equipment and assays meant to meet the needs of diverse healthcare settings including hospitals, clinics, ambulatory care settings and even homecare. Point-of-care diagnostics offer a wide range of benefits, including the factor of quicker turnaround times, the diminishing of centralized laboratories for analytics, the improvement of patient outcomes and also the cost-cutting factor. Many influencing factors for POCD include broadening base, leaflet production, rising demand for laboratory service and the growing aging population. The awareness about early detection and management of various diseases also contribute to the development of POCD. One of the major factors driving market growth is the technological development which includes devices that are made handheld/portable and have biosensors as well as connectivity features. The other factor is that lab-on-a-chip technology is a new technology which further contributes to the market growth by improving the accuracy, speed and availability of the point of care tests. On the top of that, the COVID-19 pandemic has dramatically which mostly covers rapid antigen testing and molecular diagnostics and, as a results, improves the virology of the virus. The glitches like legal barriers, reimbursement difficulties, and quality control matters could stand in the way of the market. Nevertheless, the international POCD market is seeing its potential for a considerable growth, fostered by ever-evolving technological advancements, recent trend towards decentralization of health care and increasing necessity of personalized and efficient medical diagnostics.

US Point Of Care Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 44.9 billion

Largest Segment

Infectious Disease

Fastest Growth

Glucose Testing

Growth Rate

6.1% CAGR

Global Point Of Care Diagnostics Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Point Of Care Diagnostics Market Segmental Analysis

Point of care diagnostics market is segmented based on Sample, Product, End Users, and Region. Based on Sample, the market is segmented as Blood Sample, Urine Sample, Nasal and Oropharyngeal Swabs Sample, And Other Samples. Based On Product, The Market Is Further Segmented Into Glucose Monitoring Products (Strips, Meters, Lancets & Lancing Devices),  Covid-19 Testing Products, Cardiometabolic Monitoring Products (Cardiac Marker Testing Products, Blood Gas/Electrolyte Testing Products, Hba1c Testing Products), Infectious Disease Testing Products (HIV Testing Products, Respiratory Infection Testing Products, Hepatitis C Testing Products, Healthcare-associated Infection Testing Products, Influenza Testing Products, Tropical Disease Testing Products, Sexually Transmitted Disease Testing Products, Syphilis Testing Products, Syphilis Testing Products, Chlamydia Trachomatis Testing Products, Herpes Simplex Virus (HSV) tEsting Products, Tuberculosis, Clostridium Difficile Infection Testing Products, Other Infectious Disease Testing Products), Coagulation Monitoring Products  (PT/INR Testing Products, ACT/APTT Testing Products), Pregnancy & Fertility Testing Products (Pregnancy Testing Products, Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Product, Drugs-of-abuse Testing Products, Thyroid-stimulating Hormone Testing Products, Fecal Occult Testing Products, Other Products. Based On End Users, Point Of Care Diagnostics Market Is Further Segmented into Clinical Laboratories, Ambulatory Care Facilities and Physicians Offices, Pharmacies, Retail Clinics, And E-commerce Platforms, Hospitals, Critical Care Centers, And Urgent Care Centers, Home Care Settings And Self-testing, Other End Users. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, Middle East and Africa. 

Analysis by Product  

Glucose Testing becomes the most serviced POCD division with the highest population of diabetes in the moving population's healthcare across the world. In order to make it possible for large population to conduct regular blood sugar monitoring, the medical care set do use a wide range of testing kits and devices on the market. Utilization of glucose testing is driven by urgent requirement to direct, as well as closely monitor diabetes with intervention programs and keeping positive results. Consequently, this not withstanding, glucose testing is still the most dominant POCD device globally, solely designated to meet the overwhelming healthcare needs of diabetic patients around the globe. 

From all the subcategories under Point of Care Diagnostics, Infectious disease Testing stands as the category with the fastest growth, brought about by some key factors. Fast and accurate testing for infectious diseases such as HIV, COVID-19, and emerging pathogens plays an essential role in global health care measures, which nowadays are more state-of-the-art because of the support from infectious-diseases prevention movements all over the world. Besides that, there has been advancements that has made it much easier to test rapid and point of  care tests realized faster diagnosis and thereby spurring the growth of this market. With aging population and the increasing incidence of infectious diseases in the elderly, the need for the infectious disease testing will be driven very high. Additionally, the increased international travel and trade make it necessary for utilized diagnostic to prevent transit of infectious agents, thus posing a serious implication to our public health. 

Analysis by End Use 

In 2023, the clinic laboratories segment led the market with the highest revenue share. It ranges from the simplest point-of-care glucose test to as complex as coagulation tests that the clinics are embracing in lieu of traditional lab testing. This shortens the time consumed toward further test decisions by doing away with specimen preparation and transport delays. The other advantages include reduced time to results, less cost, and better outcomes. Through awareness of the medical and organizational issues and an added bonus of the economic benefits, point-of-care diagnostics has managed to record rapid growth in the US and Europe. Out of all, the segment that is supposed to have the highest growth rate is the home care settings and self-testing since point-of-care diagnostics is convenient and less expensive in a homecare setting for the patients.

POC diagnostics at home help patients manage healthcare challenges and make decisions with swiftness. The aging population, more predisposed to chronic diseases, continues to drive steady demand for health services and is boosting the home health sector. Access to health care is improved, and such therapies reduce unwarranted visits to doctors, tránh hospital admissions, and the time required as well as the costs for traveling to providers of health services.

Global Point Of Care Diagnostics Market By Product Type

To get detailed analysis on other segments, Request For Free Sample Report

Point Of Care Diagnostics Market Regional Insights

In 2023, the market was dominated by North America with a share of 42.9% and with an increasing number of ageing people and high healthcare costs considered responsible for this domination. Therefore, the market growth is expected due to technological advancements which include miniaturized diagnostic equipment that provides accurate and rapid results, as well as proliferation of Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMRs). Nonetheless, companies like BIOMERIEUX, Abbott, Siemens Healthineers AG, BD. 

The point of care diagnostics market in the Asia Pacific region is ripe for expansion, as infrastructure in the healthcare sector improves and certain chronic conditions like diabetes, cancer, are increasingly targeted. The same will apply to infectious diseases that include HIV/AIDS, syphilis, RSV among others hence further expanding the market in this area. Adoption of POC diagnostics in different sites which comprise operating theaters, emergency units, ICUs, labs, clinics, is anticipated to increase due to their ability to provide early and efficient results.

Global Point Of Care Diagnostics Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Point Of Care Diagnostics Market Dynamics

Point Of Care Diagnostics Market Driver

Rising Incidence of Chronic and Infectious Diseases Drives Demand for Point of Care Diagnostics

  • Globally, there has been a significant increase in the occurrence of chronic diseases such as cardiovascular problems, diabetes, and numerous infectious diseases. One of the primary factors driving demand for point-of-care diagnostics during the forecast period is the rising occurrence of such disorders. According to the United Nations, about 38 million individuals have HIV/AIDS in 2019. There were 1.8 million youngsters and 36.2 million adults among them. Furthermore, human respiratory syncytial virus (RSV) is one of the most common viruses responsible for respiratory tract infections. Furthermore, the global adult diabetic population is projected to hit 643 million by 2030 and 783 million by 2045. A large increase in the prevalence of diabetes and the aforementioned chronic diseases around the world has produced a demand for rapid point of care diagnostics with the goal of properly managing such conditions, and the market is expected to grow positively internationally. 

Rising Prevalence of POC Testing Processes Drives Market Growth

  • The rising prevalence of several POC testing processes like Neuropsychological tests, urine analysis, pregnancy tests, testing for Chlamydia, cholesterol levels, international normalized ratio tests, Haemoglobin A1c tests, blood alcohol content, cardiac biomarkers, D-dimer, ionized calcium levels, arterial blood test gas analysis, electrolyte test, lactate blood test, point of care coagulation testing, Multiplexed point-of-care testing, etc. are propelling the overall market growth to a great extent. 

Restraints 

Inconsistency with Definitive Central Lab Methods

  • Due to a high number of pre- and post-analytical mistakes, point of care test findings are not properly aligned with central lab procedures. Unsuitable indications for the performance of the test, inappropriate sampling times and techniques, an insufficient information about patient conditions, and other variables such as fasting before functional tests or differences in posture/position during similar tests are examples of pre-analytical errors for point of care testing. Post-analytical errors, on the other hand, include insufficient technical validation, incorrect result assignment, and data storage issues. Point of care testing is frequently used in emergency scenarios to aid with clinical decision-making. These tests are frequently performed by nurses or clinical team members rather than physicians. Such circumstances can result in incorrect order and result documentation. These issues have the chance of leading to incorrect diagnoses and have an impact on the quality of care provided to patients. Considering these concerns, patients and doctors may decide not to go for point of care testing. This is one of the most significant barriers to increased acceptance of point of care testing.  

Lack of Accuracy of POC Diagnostics to Limit Adoption

  • Approximativeness, a major limitation in Point of care (POC) diagnostics restricts the acceptance of these markers. For POC test option, the speed and the convenience are their main advantages, however the accuracy of the result could be not a match with that of the laboratory-based tests. A notable effect is non-appropriate diagnosis, inadequate treatment decisions, and a compromised patient care, if the wrong or inaccurate results are generated. Healthcare professionals may still have shortcomings on their side and for that reason, they may opt not to use POC testing completely due to their concerns about reliability and potential negative consequences. The know-how of amending the accuracy question is of key importance in improving the healthcare professionals' trust in the POC diagnostics as well as their acceptance of this type of diagnostics in clinical practice.

Request Free Customization of this report to help us to meet your business objectives.

Point Of Care Diagnostics Market Competitive Landscape

The point of care diagnostics market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. For instance, in December 2018, Anteo Diagnostics (Australia) and Shanghai GeneoDx Biotechnology (China) announced an agreement to market, sell, and distribute Anteo’s range of AnteoBind products in China The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective and customized solutions for students.

Top Players in Global Point of Care Diagnostics Market

 

  • Abbott Laboratories (US) 
  • Siemens Healthineers AG (Germany) 
  • Quidel Corporation (US) 
  • F. Hoffman-La Roche Ltd. (Switzerland) 
  • Danaher Corporation (US) 
  • Becton, Dickinson and Company (US) 
  • Chembio Diagnostics (US) 
  • EKF Diagnostics (UK) 
  • Trinity Biotech pohlc (Ireland) 
  • Instrumentation Laboratory (US) 
  • Nova Biomedical (US) 
  • PTS Diagnostics (US) 
  • Sekisui Diagnostics (US) 
  • Thermo Fisher Scientific (US) 
  • BioMerieux S.A. (France) 
  • Alere Inc. (US) 
  • Beckman Coulter, Inc. (US) 
  • Hologic, Inc. (US) 
  • Cepheid (US) 
  • Ortho Clinical Diagnostics (US) 
  • Bio-Rad Laboratories, Inc. (US) 
  • Trividia Health (US) 
  • Chembio Diagnostic Systems, Inc. (US)

Point Of Care Diagnostics Market Recent Developments

  • In October 2023, QIAGEN received CE certification for its IVD kit and automated testing platform, NeuMoDx, boosting the company’s revenue and market share.  
  • In May 2023, Danaher Corporation launched the Dxl 9000 Access Immunoassay Analyzer, capable of running up to 215 tests per hour, thereby expanding its point-of-care diagnostics offerings.  
  • In February 2024, Roche Diagnostics announced that it had received CE mark approval for a claim extension to its Elecsys Anti-Müllerian Hormone (AMH) Plus immunoassay.

Point Of Care Diagnostics Key Market Trends

  • Technological Advancements in Point of Care Diagnostic: Major market participants have increased their focus on the use of new technologies such as artificial intelligence in the production of efficient point of care diagnostics. Lab-on-a-chip platforms wearable technologies and smart-phone interests among other technologies of its kind have led to major achievements in the point of care testing devices. This will pave the way for subsequent transformations as cloud-based Intelligent systems have opened up numerous possibilities for future revolutions. The formation of new diagnostic systems has been influenced by miniaturization in chip technology, microfluidics and innovative biosensors. One of the key drivers of POCT is lab-on-a-chip technology, notably in infectious illness detection. Microbiological culture, enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR) can now be employed at the point of care thanks to lab-on-a-chip technology.

Point Of Care Diagnostics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research. 

According to our Point of care diagnostics market analysis, Infectious diseases point of care testing held the highest revenue share. Diabetes prevalence and the introduction of portable diagnostic equipment are predicted to drive the market growth. North America held highest market share and expected to rule the point of care diagnostics market during the forecast period. The regional market is projected to grow as a result of massive use of cutting-edge point-of-care diagnostics to identify a variety of infectious and chronic diseases, as well as the availability of beneficial reimbursement policies.

Report Metric Details
Market size value in 2022 USD 47.64 Billion
Market size value in 2031 USD 81.17 Billion
Growth Rate 6.1%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Sample
    • Blood Samples, Urine Samples, Nasal & Oropharyngeal Swabs, and Other Samples
  • Product Type
    • Glucose Monitoring Products (Strips, Meters, Lancets & Lancing Devices), Covid-19 Testing Products, Cardiometabolic Monitoring Products (Cardiac Marker Testing Products, Blood Gas/Electrolyte Testing Products, HBA1C Testing Products), Infectious Disease Testing Products (HIV Testing Products, Respiratory Infection Testing Products, Hepatitis C Testing Products, Healthcare-associated Infection Testing Products, Influenza Testing Products, Tropical Disease Testing Products, Sexually Transmitted Disease Testing Products, Syphilis Testing Products, Syphilis Testing Products, Chlamydia Trachomatis Testing Products, Herpes Simplex Virus (HSV) Testing Products, Tuberculosis, Clostridium Difficile Infection Testing Products, Other Infectious Disease Testing Products), Coagulation Monitoring Products (PT/INR Testing Products, ACT/APTT Testing Products), Pregnancy & Fertility Testing Products (Pregnancy Testing Products, Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Product, Drugs-Of-Abuse Testing Products, Thyroid-Stimulating Hormone Testing Products, Fecal Occult Testing Products, and Other Products)
  • End-Users
    • Clinical Laboratories, Ambulatory Care Facilities and Physicians Offices, Pharmacies, Retail Clinics, and E-Commerce Platforms, Hospitals, Critical Care Centers, and Urgent Care Centers, Home Care Settings and Self-Testing, and Other End Users
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories (US) 
  • Siemens Healthineers AG (Germany) 
  • Quidel Corporation (US) 
  • F. Hoffman-La Roche Ltd. (Switzerland) 
  • Danaher Corporation (US) 
  • Becton, Dickinson and Company (US) 
  • Chembio Diagnostics (US) 
  • EKF Diagnostics (UK) 
  • Trinity Biotech pohlc (Ireland) 
  • Instrumentation Laboratory (US) 
  • Nova Biomedical (US) 
  • PTS Diagnostics (US) 
  • Sekisui Diagnostics (US) 
  • Thermo Fisher Scientific (US) 
  • BioMerieux S.A. (France) 
  • Alere Inc. (US) 
  • Beckman Coulter, Inc. (US) 
  • Hologic, Inc. (US) 
  • Cepheid (US) 
  • Ortho Clinical Diagnostics (US) 
  • Bio-Rad Laboratories, Inc. (US) 
  • Trividia Health (US) 
  • Chembio Diagnostic Systems, Inc. (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Point Of Care Diagnostics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Point Of Care Diagnostics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Point Of Care Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Point Of Care Diagnostics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Point Of Care Diagnostics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Point Of Care Diagnostics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Point of Care Diagnostics Market size was valued at USD 47.64 Billion in 2022 and is poised to grow from USD 50.54 Billion in 2023 to USD 81.17 Billion by 2031, at a CAGR of 6.1% during the forecast period (2024-2031).

The point of care diagnostics market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. For instance, in December 2018, Anteo Diagnostics (Australia) and Shanghai GeneoDx Biotechnology (China) announced an agreement to market, sell, and distribute Anteo’s range of AnteoBind products in China The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective and customized solutions for students. 'Abbott Laboratories (US) ', 'Siemens Healthineers AG (Germany) ', 'Quidel Corporation (US) ', 'F. Hoffman-La Roche Ltd. (Switzerland) ', 'Danaher Corporation (US) ', 'Becton, Dickinson and Company (US) ', 'Chembio Diagnostics (US) ', 'EKF Diagnostics (UK) ', 'Trinity Biotech pohlc (Ireland) ', 'Instrumentation Laboratory (US) ', 'Nova Biomedical (US) ', 'PTS Diagnostics (US) ', 'Sekisui Diagnostics (US) ', 'Thermo Fisher Scientific (US) ', 'BioMerieux S.A. (France) ', 'Alere Inc. (US) ', 'Beckman Coulter, Inc. (US) ', 'Hologic, Inc. (US) ', 'Cepheid (US) ', 'Ortho Clinical Diagnostics (US) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Trividia Health (US) ', 'Chembio Diagnostic Systems, Inc. (US)'

Technological Advancements in Point of Care Diagnostic: Major market participants have increased their focus on the use of new technologies such as artificial intelligence in the production of efficient point of care diagnostics. Lab-on-a-chip platforms wearable technologies and smart-phone interests among other technologies of its kind have led to major achievements in the point of care testing devices. This will pave the way for subsequent transformations as cloud-based Intelligent systems have opened up numerous possibilities for future revolutions. The formation of new diagnostic systems has been influenced by miniaturization in chip technology, microfluidics and innovative biosensors. One of the key drivers of POCT is lab-on-a-chip technology, notably in infectious illness detection. Microbiological culture, enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR) can now be employed at the point of care thanks to lab-on-a-chip technology.

In 2023, the market was dominated by North America with a share of 42.9% and with an increasing number of ageing people and high healthcare costs considered responsible for this domination. Therefore, the market growth is expected due to technological advancements which include miniaturized diagnostic equipment that provides accurate and rapid results, as well as proliferation of Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMRs). Nonetheless, companies like BIOMERIEUX, Abbott, Siemens Healthineers AG, BD. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35I2098

$5,300
BUY NOW GET FREE SAMPLE